Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prealbumin | 6 | 2021 | 19 | 1.190 |
Why?
|
| Dependovirus | 8 | 2025 | 718 | 0.900 |
Why?
|
| Genetic Therapy | 10 | 2025 | 799 | 0.850 |
Why?
|
| Huntington Disease | 2 | 2025 | 157 | 0.850 |
Why?
|
| Amyloidosis | 2 | 2021 | 66 | 0.760 |
Why?
|
| Genetic Vectors | 6 | 2025 | 887 | 0.750 |
Why?
|
| Transduction, Genetic | 2 | 2019 | 239 | 0.700 |
Why?
|
| Amyloid Neuropathies, Familial | 4 | 2014 | 16 | 0.680 |
Why?
|
| Gene Editing | 2 | 2022 | 323 | 0.650 |
Why?
|
| Gene Expression | 3 | 2020 | 851 | 0.650 |
Why?
|
| Antigens, Ly | 1 | 2019 | 44 | 0.630 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 86 | 0.600 |
Why?
|
| Central Nervous System | 2 | 2019 | 197 | 0.580 |
Why?
|
| Membrane Proteins | 1 | 2019 | 908 | 0.420 |
Why?
|
| Lysosomes | 1 | 2013 | 168 | 0.370 |
Why?
|
| Liver | 2 | 2014 | 868 | 0.360 |
Why?
|
| Gene Transfer Techniques | 3 | 2019 | 322 | 0.360 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 1297 | 0.310 |
Why?
|
| Transgenes | 3 | 2023 | 188 | 0.270 |
Why?
|
| Time Perception | 1 | 2025 | 6 | 0.230 |
Why?
|
| Dyslexia | 1 | 2025 | 8 | 0.230 |
Why?
|
| Mice | 10 | 2025 | 10994 | 0.220 |
Why?
|
| Zinc Fingers | 1 | 2025 | 103 | 0.220 |
Why?
|
| Auditory Perception | 1 | 2025 | 37 | 0.220 |
Why?
|
| Huntingtin Protein | 1 | 2025 | 145 | 0.220 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2024 | 15 | 0.220 |
Why?
|
| Tay-Sachs Disease | 2 | 2022 | 46 | 0.210 |
Why?
|
| Cues | 1 | 2025 | 75 | 0.210 |
Why?
|
| Heterozygote | 1 | 2024 | 171 | 0.210 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 223 | 0.200 |
Why?
|
| Dystrophin | 1 | 2023 | 31 | 0.200 |
Why?
|
| Lipids | 1 | 2025 | 319 | 0.190 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 43 | 0.190 |
Why?
|
| Animals | 12 | 2025 | 20955 | 0.190 |
Why?
|
| Genes, Reporter | 2 | 2019 | 260 | 0.190 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2022 | 24 | 0.180 |
Why?
|
| Sandhoff Disease | 1 | 2020 | 36 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 147 | 0.160 |
Why?
|
| Cisterna Magna | 1 | 2019 | 15 | 0.160 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 77 | 0.150 |
Why?
|
| Polyneuropathies | 2 | 2010 | 11 | 0.150 |
Why?
|
| Species Specificity | 1 | 2019 | 334 | 0.150 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 176 | 0.140 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 2237 | 0.140 |
Why?
|
| Genotype | 1 | 2019 | 668 | 0.140 |
Why?
|
| Humans | 12 | 2025 | 64270 | 0.130 |
Why?
|
| Brain | 1 | 2025 | 1581 | 0.130 |
Why?
|
| Peripheral Nervous System | 1 | 2014 | 11 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 40 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 36 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2014 | 130 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 60 | 0.110 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 49 | 0.110 |
Why?
|
| Choroid Plexus | 1 | 2013 | 16 | 0.100 |
Why?
|
| Glycosylation | 1 | 2013 | 138 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 294 | 0.090 |
Why?
|
| Mutation | 4 | 2025 | 2633 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2013 | 220 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 181 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2013 | 626 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 231 | 0.080 |
Why?
|
| Propanolamines | 1 | 2010 | 10 | 0.080 |
Why?
|
| Carbazoles | 1 | 2010 | 14 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 306 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 153 | 0.080 |
Why?
|
| Biomarkers | 2 | 2022 | 1431 | 0.080 |
Why?
|
| Male | 4 | 2025 | 30320 | 0.080 |
Why?
|
| Apoptosis | 3 | 2010 | 1095 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1494 | 0.070 |
Why?
|
| Cell Line | 1 | 2013 | 2057 | 0.070 |
Why?
|
| Taurochenodeoxycholic Acid | 1 | 2008 | 3 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 256 | 0.070 |
Why?
|
| Amyloidosis, Familial | 1 | 2007 | 2 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1622 | 0.070 |
Why?
|
| Coccidiosis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Neospora | 1 | 2007 | 1 | 0.070 |
Why?
|
| Antibodies, Protozoan | 1 | 2007 | 53 | 0.060 |
Why?
|
| Acoustic Stimulation | 1 | 2025 | 52 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2024 | 5 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2025 | 151 | 0.050 |
Why?
|
| Alleles | 1 | 2025 | 449 | 0.050 |
Why?
|
| Models, Animal | 2 | 2019 | 240 | 0.050 |
Why?
|
| Locomotion | 1 | 2024 | 117 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2023 | 125 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 186 | 0.050 |
Why?
|
| G(M1) Ganglioside | 1 | 2022 | 12 | 0.050 |
Why?
|
| Gangliosides | 1 | 2022 | 19 | 0.050 |
Why?
|
| Female | 2 | 2025 | 33381 | 0.050 |
Why?
|
| Cats | 1 | 2022 | 89 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2022 | 84 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2022 | 296 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 1223 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 103 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 3449 | 0.040 |
Why?
|
| G(M2) Ganglioside | 1 | 2020 | 10 | 0.040 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2020 | 20 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 46 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 182 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 59 | 0.040 |
Why?
|
| Catheters | 1 | 2019 | 78 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 140 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2010 | 327 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 237 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2023 | 803 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2010 | 304 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 17134 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 727 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 901 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 1257 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 4781 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1669 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2218 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 182 | 0.020 |
Why?
|
| Methionine | 1 | 2008 | 57 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 100 | 0.020 |
Why?
|
| fas Receptor | 1 | 2008 | 57 | 0.020 |
Why?
|
| Tyrosine | 1 | 2008 | 94 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 68 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 105 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 199 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 100 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 175 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 302 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2008 | 187 | 0.020 |
Why?
|
| DNA Damage | 1 | 2007 | 289 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 891 | 0.010 |
Why?
|